SCOPUS 정보 검색 플랫폼

Volumn 526, Issue 2, 2012, Pages 139-145

Recombinant antibody mixtures: Production strategies and cost considerations

(5) Rasmussen, Soren K a Næsted, Henrik a Müller, Christian a Tolstrup, Anne B a Frandsen, Torben P a

Author keywords

Antibody mixtures; Cell banking; Cell line generation; CHO cell lines; CMC; Cost of goods; Manufacturing; Protein characterization; Recombinant antibodies

Indexed keywords

IMMUNOGLOBULIN G; RECOMBINANT ANTIBODY;

ANALYTICAL RESEARCH; ANTIBODY PRODUCTION; CELL LINE; COST; DRUG MANUFACTURE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIBODIES; BIOTECHNOLOGY; CLONING, MOLECULAR; HUMANS; RECOMBINANT PROTEINS;

EID: 84865680216 PISSN: 00039861 EISSN: 10960384 Source Type: Journal
DOI: 10.1016/j.abb.2012.07.001 Document Type: Review

Times cited : (37)

References (37)

1
- 77957361348
- A.L. Nelson, E. Dhimolea, and J.M. Reichert Nat. Rev. Drug Discov. 9 2010 767 774
- (2010) Nat. Rev. Drug Discov. , vol.9 , pp. 767-774
- Nelson, A.L.¹ Dhimolea, E.² Reichert, J.M.³

2
- 60849128549
- J.M. Reichert Curr. Pharm. Biotechnol. 9 2008 423 430
- (2008) Curr. Pharm. Biotechnol. , vol.9 , pp. 423-430
- Reichert, J.M.¹

3
- 67649886201
- P.D. Senter Curr Opin Chem. Biol. 13 2009 235 244
- (2009) Curr Opin Chem. Biol. , vol.13 , pp. 235-244
- Senter, P.D.¹

4
- 38949192547
- R.V. Chari Acc. Chem. Res. 41 2008 98 107
- (2008) Acc. Chem. Res. , vol.41 , pp. 98-107
- Chari, R.V.¹

5
- 74849092615
- B.A. Teicher Curr. Cancer Drug Targets 9 2009 982 1004
- (2009) Curr. Cancer Drug Targets , vol.9 , pp. 982-1004
- Teicher, B.A.¹

6
- 77955312203
- S.C. Alley, N.M. Okeley, and P.D. Senter Curr. Opin. Chem. Biol. 14 2010 529 537
- (2010) Curr. Opin. Chem. Biol. , vol.14 , pp. 529-537
- Alley, S.C.¹ Okeley, N.M.² Senter, P.D.³

7
- 44649184200
- E. Oflazoglu, K.M. Kissler, E.L. Sievers, I.S. Grewal, and H.P. Gerber Br. J. Haematol. 142 2008 69 73
- (2008) Br. J. Haematol. , vol.142 , pp. 69-73
- Oflazoglu, E.¹ Kissler, K.M.² Sievers, E.L.³ Grewal, I.S.⁴ Gerber, H.P.⁵

8
- 79952092706
- H.A. Burris III, H.S. Rugo, S.J. Vukelja, C.L. Vogel, R.A. Borson, S. Limentani, E. Tan-Chiu, I.E. Krop, R.A. Michaelson, S. Girish, L. Amler, M. Zheng, Y.W. Chu, B. Klencke, and J.A. O'Shaughnessy J. Clin. Oncol. 29 2011 398 405
- (2011) J. Clin. Oncol. , vol.29 , pp. 398-405
- Burris Iii, H.A.¹ Rugo, H.S.² Vukelja, S.J.³ Vogel, C.L.⁴ Borson, R.A.⁵ Limentani, S.⁶ Tan-Chiu, E.⁷ Krop, I.E.⁸ Michaelson, R.A.⁹ Girish, S.¹⁰ Amler, L.¹¹ Zheng, M.¹² Chu, Y.W.¹³ Klencke, B.¹⁴ O'Shaughnessy, J.A.¹⁵

9
- 80555156163
- S. Fagete, and N. Fischer BioDrugs 25 2011 357 364
- (2011) BioDrugs , vol.25 , pp. 357-364
- Fagete, S.¹ Fischer, N.²

10
- 77955690974
- A.M. Cuesta, N. Sainz-Pastor, J. Bonet, B. Oliva, and L. varez-Vallina Trends Biotechnol. 28 2010 355 362
- (2010) Trends Biotechnol. , vol.28 , pp. 355-362
- Cuesta, A.M.¹ Sainz-Pastor, N.² Bonet, J.³ Oliva, B.⁴ Varez-Vallina, L.⁵

11
- 77953188563
- A. Thakur, and L.G. Lum Curr. Opin. Mol. Ther. 12 2010 340 349
- (2010) Curr. Opin. Mol. Ther. , vol.12 , pp. 340-349
- Thakur, A.¹ Lum, L.G.²

12
- 85044710140
- S.J. Demarest, K. Hariharan, and J. Dong MAbs. 3 2011 338 351
- (2011) MAbs. , vol.3 , pp. 338-351
- Demarest, S.J.¹ Hariharan, K.² Dong, J.³

13
- 36849087921
- W.A. Marasco, and J. Sui Nat. Biotechnol. 25 2007 1421 1434
- (2007) Nat. Biotechnol. , vol.25 , pp. 1421-1434
- Marasco, W.A.¹ Sui, J.²

14
- 79952276644
- J. Baselga, and S.M. Swain Clin Breast Cancer 10 2010 489 491
- (2010) Clin Breast Cancer , vol.10 , pp. 489-491
- Baselga, J.¹ Swain, S.M.²

15
- 76549085643
- M.W. Pedersen, H.J. Jacobsen, K. Koefoed, A. Hey, C. Pyke, J.S. Haurum, and M. Kragh Cancer Res. 70 2010 588 597
- (2010) Cancer Res. , vol.70 , pp. 588-597
- Pedersen, M.W.¹ Jacobsen, H.J.² Koefoed, K.³ Hey, A.⁴ Pyke, C.⁵ Haurum, J.S.⁶ Kragh, M.⁷

16
- 80052843636
- N.J. Skartved, H.J. Jacobsen, M.W. Pedersen, P.F. Jensen, J.W. Sen, T.K. Jorgensen, A. Hey, and M. Kragh Clin. Cancer Res. 17 2011 5962 5972
- (2011) Clin. Cancer Res. , vol.17 , pp. 5962-5972
- Skartved, N.J.¹ Jacobsen, H.J.² Pedersen, M.W.³ Jensen, P.F.⁴ Sen, J.W.⁵ Jorgensen, T.K.⁶ Hey, A.⁷ Kragh, M.⁸

17
- 81255210858
- K. Koefoed, L. Steinaa, J.N. Soderberg, I. Kjaer, H.J. Jacobsen, P.J. Meijer, J.S. Haurum, A. Jensen, M. Kragh, P.S. Andersen, and M.W. Pedersen MAbs. 3 2011 584 595
- (2011) MAbs. , vol.3 , pp. 584-595
- Koefoed, K.¹ Steinaa, L.² Soderberg, J.N.³ Kjaer, I.⁴ Jacobsen, H.J.⁵ Meijer, P.J.⁶ Haurum, J.S.⁷ Jensen, A.⁸ Kragh, M.⁹ Andersen, P.S.¹⁰ Pedersen, M.W.¹¹

18
- 79960471593
- T.P. Frandsen, H. Naested, S.K. Rasmussen, P. Hauptig, F.C. Wiberg, L.K. Rasmussen, A.M. Jensen, P. Persson, M. Wiken, A. Engstrom, Y. Jiang, S.J. Thorpe, C. Forberg, and A.B. Tolstrup Biotechnol. Bioeng. 2011 2171 2181
- (2011) Biotechnol. Bioeng. , pp. 2171-2181
- Frandsen, T.P.¹ Naested, H.² Rasmussen, S.K.³ Hauptig, P.⁴ Wiberg, F.C.⁵ Rasmussen, L.K.⁶ Jensen, A.M.⁷ Persson, P.⁸ Wiken, M.⁹ Engstrom, A.¹⁰ Jiang, Y.¹¹ Thorpe, S.J.¹² Forberg, C.¹³ Tolstrup, A.B.¹⁴

19
- 33744498904
- F.C. Wiberg, S.K. Rasmussen, T.P. Frandsen, L.K. Rasmussen, K. Tengbjerg, V.W. Coljee, J. Sharon, C.Y. Yang, S. Bregenholt, L.S. Nielsen, J.S. Haurum, and A.B. Tolstrup Biotechnol. Bioeng. 94 2006 396 405
- (2006) Biotechnol. Bioeng. , vol.94 , pp. 396-405
- Wiberg, F.C.¹ Rasmussen, S.K.² Frandsen, T.P.³ Rasmussen, L.K.⁴ Tengbjerg, K.⁵ Coljee, V.W.⁶ Sharon, J.⁷ Yang, C.Y.⁸ Bregenholt, S.⁹ Nielsen, L.S.¹⁰ Haurum, J.S.¹¹ Tolstrup, A.B.¹²

20
- 80155150449
- D. Holmes Nat. Rev. Drug Discov. 10 2011 798 800
- (2011) Nat. Rev. Drug Discov. , vol.10 , pp. 798-800
- Holmes, D.¹

21
- 84865679467
- Press Release: XOMA Ltd. XOMA 3AB, a Novel Triple-Antibody Anti-Botulinum Neurotoxin Product, Enters Phase 1 Clinical Testing (2011).
- Press Release: XOMA Ltd. XOMA 3AB, a Novel Triple-Antibody Anti-Botulinum Neurotoxin Product, Enters Phase 1 Clinical Testing (2011).

22
- 77955342213
- John de Kruif, Arjen Kramer, Roy Nijhuis, Vanessa van der Zande, Renate den Blanken, Carina Clements, Therèse Visser, Rob Keehnen, Marcel den Hartog, Mark Throsby, and Ton Logtenberg Biotechnol. Bioeng. 106 2010 741 750
- (2010) Biotechnol. Bioeng. , vol.106 , pp. 741-750
- Kruif, J.D.¹ Kramer, A.² Nijhuis, R.³ Zande, V.V.D.⁴ Blanken, R.D.⁵ Clements, C.⁶ Visser, T.⁷ Keehnen, R.⁸ Hartog, M.D.⁹ Throsby, M.¹⁰ Logtenberg, T.¹¹

23
- 77954959328
- L.S. Nielsen, A. Baer, C. Muller, K. Gregersen, N.T. Monster, S.K. Rasmussen, D. Weilguny, and A.B. Tolstrup Mol. Biotechnol. 2010 257 266
- (2010) Mol. Biotechnol. , pp. 257-266
- Nielsen, L.S.¹ Baer, A.² Muller, C.³ Gregersen, K.⁴ Monster, N.T.⁵ Rasmussen, S.K.⁶ Weilguny, D.⁷ Tolstrup, A.B.⁸

24
- 34247344863
- S.K. Rasmussen, L.K. Rasmussen, D. Weilguny, and A.B. Tolstrup Biotechnol. Lett. 29 2007 845 852
- (2007) Biotechnol. Lett. , vol.29 , pp. 845-852
- Rasmussen, S.K.¹ Rasmussen, L.K.² Weilguny, D.³ Tolstrup, A.B.⁴

25
- 35548962773
- T. Logtenberg Trends Biotechnol. 25 2007 390 394
- (2007) Trends Biotechnol. , vol.25 , pp. 390-394
- Logtenberg, T.¹

26
- 33748165728
- P.S. Andersen, M. Haahr-Hansen, V.W. Coljee, F.R. Hinnerfeldt, K. Varming, S. Bregenholt, and J.S. Haurum Mol. Immunol. 44 2007 412 422
- (2007) Mol. Immunol. , vol.44 , pp. 412-422
- Andersen, P.S.¹ Haahr-Hansen, M.² Coljee, V.W.³ Hinnerfeldt, F.R.⁴ Varming, K.⁵ Bregenholt, S.⁶ Haurum, J.S.⁷

27
- 84865685548
- Meeting abstract American Society of Hematology (ASH)
- T. Robak et al. Meeting abstract American Society of Hematology (ASH). Final Results from a Phase II Trial with the First in Class Recombinant Polyclonal Antibody Product Rozrolimupab in Primary Immune Thrombocytopenia (2011).
- (2011) Final Results from A Phase II Trial with the First in Class Recombinant Polyclonal Antibody Product Rozrolimupab in Primary Immune Thrombocytopenia
- Robak, T.¹

28
- 77958518175
- F. Li, N. Vijayasankaran, A.Y. Shen, R. Kiss, and A. Amanullah MAbs. 2 2010 466 479
- (2010) MAbs. , vol.2 , pp. 466-479
- Li, F.¹ Vijayasankaran, N.² Shen, A.Y.³ Kiss, R.⁴ Amanullah, A.⁵

29
- 0025847620
- S. O'Gorman, D.T. Fox, and G.M. Wahl Science 251 1991 1351 1355
- (1991) Science , vol.251 , pp. 1351-1355
- O'Gorman, S.¹ Fox, D.T.² Wahl, G.M.³

30
- 0028148244
- B. Sauer Curr. Opin. Biotechnol. 5 1994 521 527
- (1994) Curr. Opin. Biotechnol. , vol.5 , pp. 521-527
- Sauer, B.¹

31
- 84865687163
- S.C. Jun, M.S. Kim, J.Y. Baik, S.O. Hwang, and G.M. Lee Appl. Microbiol. Biotechnol. 69 2005 162 169
- (2005) Appl. Microbiol. Biotechnol. , vol.69 , pp. 162-169
- Jun, S.C.¹ Kim, M.S.² Baik, J.Y.³ Hwang, S.O.⁴ Lee, G.M.⁵

32
- 33845925097
- M.C. de la Cruz Edmonds, M. Tellers, C. Chan, P. Salmon, D.K. Robinson, and J. Markusen Mol. Biotechnol. 34 2006 179 190
- (2006) Mol. Biotechnol. , vol.34 , pp. 179-190
- De La Cruz Edmonds, M.C.¹ Tellers, M.² Chan, C.³ Salmon, P.⁴ Robinson, D.K.⁵ Markusen, J.⁶

33
- 84865674674
- S.K. Rasmussen, L. Nielsen, C. Müller, T. Bouquin, H. Næsted, N.T. Monster, F. Nygaard, D. Weilguny, T.P. Frandsen, and A.B. Tolstrup BMC Proc. 5 Suppl 8 2011 1 3
- (2011) BMC Proc. , vol.5 , Issue.SUPPL. 8 , pp. 1-3
- Rasmussen, S.K.¹ Nielsen, L.² Müller, C.³ Bouquin, T.⁴ Næsted, H.⁵ Monster, N.T.⁶ Nygaard, F.⁷ Weilguny, D.⁸ Frandsen, T.P.⁹ Tolstrup, A.B.¹⁰

34
- 80052788049
- J.H. Chon, and G. Zarbis-Papastoitsis Nat. Biotechnol. 2011 458 463
- (2011) Nat. Biotechnol. , pp. 458-463
- Chon, J.H.¹ Zarbis-Papastoitsis, G.²

35
- 77950879193
- M.E. Rodrigues, A.R. Costa, M. Henriques, J. Azeredo, and R. Oliveira Biotechnol Prog. 26 2010 332 351
- (2010) Biotechnol Prog. , vol.26 , pp. 332-351
- Rodrigues, M.E.¹ Costa, A.R.² Henriques, M.³ Azeredo, J.⁴ Oliveira, R.⁵

36
- 84863548879
- E.S. Langer BioProcess Int. 6 8 2008 28 30
- (2008) BioProcess Int. , vol.6 , Issue.8 , pp. 28-30
- Langer, E.S.¹

37
- 84865679464
- Press Release: Adimab LLC & Merrimack Pharmaceuticals, Inc.
- Press Release: Adimab LLC & Merrimack Pharmaceuticals, Inc. Three Adimab Antibodies Enter Human Clinical Trials (2012)
- (2012) Three Adimab Antibodies Enter Human Clinical Trials

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.